Botanix secures commitments for A $10 million via institutional placement
Botanix lifted a trading halt this morning, sharing news that it has secured commitments ofA$10.0million via institutional investors to accelerate the marketing and launch activities forSofpironium Bromide. Proceeds from the Placement will be used to progress Botanix’s lead developmentprogram, Sofpironium Bromide gel (15%), including costs associated with completingFDA review, manufacturing, satisfying milestone payments and preparing […]